NEWLEOS
Live / Allowed — Published for opposition (as of 10 Mar 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 04 Jun 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99216957
- Mark type
- Stylized text
- Filed
- 04 Jun 2025
- Published for opposition
- 10 Mar 2026
- Attorney of record
- Kelley B. Harrington
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and therapeutics being pharmaceutical preparations for the treatment and prevention of neurological and behavioral diseases and disorders
- Class 042 — Scientific and technological services: Pharmaceutical research and development; Providing medical and scientific research information; all of the foregoing in the field of treatment and prevention of neurological and behavioral diseases and disorders
Owner
- Newleos Therapeutics, Inc., Boston, MA, US
- Newleos Therapeutics, Inc., Boston, MA, US
Prosecution history
- 10 Mar 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 10 Mar 2026 — PUBLISHED FOR OPPOSITION
- 04 Mar 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 10 Feb 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 10 Feb 2026 — EXAMINER'S AMENDMENT ENTERED
- 10 Feb 2026 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 10 Feb 2026 — EXAMINERS AMENDMENT E-MAILED
- 10 Feb 2026 — EXAMINERS AMENDMENT -WRITTEN
- 10 Feb 2026 — EXAMINER'S AMENDMENT ENTERED
- 10 Feb 2026 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 10 Feb 2026 — EXAMINERS AMENDMENT E-MAILED
- 10 Feb 2026 — EXAMINERS AMENDMENT -WRITTEN
- 23 Jan 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 23 Jan 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 23 Jan 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED